Apis Capital Advisors LLC Purchases Shares of 138,000 Hinge Health Inc. $HNGE

Apis Capital Advisors LLC purchased a new stake in shares of Hinge Health Inc. (NYSE:HNGE) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 138,000 shares of the company’s stock, valued at approximately $6,410,000. Hinge Health comprises 1.1% of Apis Capital Advisors LLC’s holdings, making the stock its 26th biggest holding.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Marshall Wace LLP purchased a new stake in shares of Hinge Health in the second quarter worth about $367,000. Sei Investments Co. purchased a new stake in shares of Hinge Health in the second quarter worth about $869,000. Squarepoint Ops LLC purchased a new stake in shares of Hinge Health in the second quarter worth about $19,706,000. Raymond James Financial Inc. purchased a new stake in shares of Hinge Health in the second quarter worth about $3,258,000. Finally, Sandia Investment Management LP purchased a new stake in shares of Hinge Health in the second quarter worth about $657,000.

Analysts Set New Price Targets

HNGE has been the subject of several analyst reports. KeyCorp upped their target price on Hinge Health from $75.00 to $90.00 and gave the stock an “overweight” rating in a research report on Friday, June 12th. Wall Street Zen cut Hinge Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 6th. Truist Financial increased their price target on Hinge Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research report on Thursday, June 11th. Stifel Nicolaus set a $79.00 price target on Hinge Health in a research report on Wednesday, June 10th. Finally, Citigroup reiterated an “outperform” rating on shares of Hinge Health in a research report on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $75.13.

Insider Transactions at Hinge Health

In related news, CEO Daniel Antonio Perez sold 45,456 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $55.05, for a total transaction of $2,502,352.80. Following the completion of the sale, the chief executive officer directly owned 35,470 shares in the company, valued at approximately $1,952,623.50. This trade represents a 56.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President James Pursley sold 16,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $53.79, for a total value of $860,640.00. Following the transaction, the president owned 780,223 shares in the company, valued at approximately $41,968,195.17. This trade represents a 2.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 554,600 shares of company stock valued at $29,859,068 in the last three months. 18.92% of the stock is currently owned by insiders.

Hinge Health Stock Down 1.1%

HNGE opened at $67.07 on Thursday. The stock has a fifty day moving average of $52.21 and a 200-day moving average of $46.39. The firm has a market capitalization of $5.19 billion and a P/E ratio of -5.44. Hinge Health Inc. has a 12-month low of $30.08 and a 12-month high of $70.72.

Hinge Health (NYSE:HNGE) last released its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. The company had revenue of $182.31 million during the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.Hinge Health’s revenue for the quarter was up 47.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.30 EPS. On average, analysts expect that Hinge Health Inc. will post 1.33 earnings per share for the current fiscal year.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.